| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |